Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-11-02
1990-10-02
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514265, 544118, 544273, 544267, 544272, 544276, C07D47306
Patent
active
049607731
ABSTRACT:
The present invention relates to new compounds of Formula I ##STR1## and physiologically acceptable salts thereof wherein A and B stand for oxygen or --CH.sub.2 group with the proviso that if A stands for oxygen, then B stands for --CH.sub.2 group and R stands for hydrogen and, if A represents a --CH.sub.2 group, then B stands for oxygen, R stands for a --CH.sub.2 Q group wherein Q stands for hydrogen, and pyrrolidino, piperidino or morpholino and a process for the preparation thereof and pharmaceutical compositions containing as active ingredient a compound of the Formula (I) or a physiologically acceptable salt thereof.
REFERENCES:
patent: 4565817 (1986-01-01), Korbonits et al.
patent: 4840949 (1989-06-01), Korbonits et al.
Heja Gergely
Korbonits Dezso
Minker Emil
Szomor Maria
Chinoin Gyogyszer- es Vegyeszeti Termekek Gyara RT.
Dubno Herbert
Ford John M.
Myers Jonathan
LandOfFree
Xanthine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-292632